期刊文献+

经皮腔内血管支架成形术治疗颅内外血管狭窄16例 被引量:1

Percutaneous transluminal angioplasty (PTA) stenting for intracranial and extracranial artery stenosis of 16 cases
下载PDF
导出
摘要 目的探讨经皮腔内血管支架成形术治疗颅内外血管狭窄。方法对16例颅内外脑血管狭窄的患者,由多学科参加进行术前评估后,行经皮腔内血管支架成形术治疗。结果16例患者中15例患者症状即刻消失或好转,术后残余狭窄率小于20%。其中1例因血管严重迂曲,支架无法到位,手术失败。1例因血压控制欠佳于术后48h出现高灌注综合征,继发颅内出血,经治疗后恢复良好。1例行颈内动脉支架植入术后出现持续低血压,经升压及补液对症治疗5d后血压正常。对15例患者术后随访3 ̄14个月,无患者发生再狭窄。结论经皮腔内血管支架成形术治疗颅内外血管狭窄创伤小、疗效好,但风险高,应注重术前评估、手术操作、并发症防治、围手术期监护及发挥团队协作精神。 [Objective] To investigate the effect of PTA stenting for intracranial and extracranial artery stenosis. [Methods] The procedure of PTA stenting for intracranial and extracranial artery stenosis was performed after the preoperative imaging of subjects in 16 cases. [Results] 15 patients' signs of 16 cases disappeared or changed better immediately. Immediate residual stenosis is below 20%. During these cases, one patient's stent couldn't go into the right position because of the bad path (which vein was serious convolute), it was failing. Hyperperfusion syndrom occurred in one case after 48 hours because the blood pressure was beyond control. Intracranial bleeding appeared. He recovered after treatment. Continous hypotension occured in an intracranial artery stenosis. After stepping up the blood pressure, supplying fluid and heteropathy, the blood pressure got to normal level after 5 days. No one in the 15 cases restenosised following 3-14 months. [Conclusion] PTA stenting for intracranial and extracranial artery stenosis has low traumas, better efficacy, but high risk. We should pay attention to preoperative imaging, operation procedure, protected against complication, perioperative custodial care and carrying forward the spirit of community cooperation.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第21期3323-3326,共4页 China Journal of Modern Medicine
关键词 颅内外动脉狭窄 血管成形术 支架 多学科一体化 intracranial and extracranial artery stenosis angioplasty stent systematic treatment with subjects
  • 相关文献

参考文献8

二级参考文献9

  • 1[9]Wholey MH, Al-Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardio vasc Interv, 2003, 60: 259-266.
  • 2[10]Yadav JS. Mark H, Wholey, et al. Protected carotid ar tery stenting versus endarterectomy in high-risk patients.The New England Journal of Medicine, 2004, 351: 1493-1501.
  • 3[3]McCarthy W J, Wang R, Pearce WH, et al. Carotid endarterectomy with an occluded contralateral carotid artery. Am J Surg, 1993, 166: 168-172.
  • 4[4]Riles TS, Imparato AM, Jacobowitz GR, et al. The cause of perioperative stroke after carotid endarterectomy. J Vasc Surg, 1994, 19: 206-216.
  • 5[5]Appleberg M, Cottier D, Crozier J, et al. Carotid endarterectomy for asymptomatic carotid artery stenosis: patients with severe bilateral diseasa A high risk subgroup, Aust N Z J Surg, 1995, 65: 160-165.
  • 6[6]Wholey MH, Wholey M, Bergeron P. et al. Current global status of carotid artery stent placement. Cathet Cardiovase Diagn, 1998, 44: 1-6.
  • 7[7]Wholey MH, Wholey M, Eles G, et al. Endovascular stents for carotid artery occlusive disease. J Endovasc Surg, 1997, 4: 326-338.
  • 8[8]Yadav JS, Roubin GS, Vitek J, et al. Elective stenting of the extracranial carotid arteries. Circulation, 1997, 95:367 -381.
  • 9李慎茂,董宗俊,武剑,朱凤水,董岩,李坤成,华扬,王拥军.血管内支架在治疗颈内动脉高度狭窄疾病中的应用[J].中华放射学杂志,2000,34(12):817-819. 被引量:76

共引文献187

同被引文献18

  • 1肖越勇,张金山,崔福斋,孟波.生物可降解性血管内支架的制备及其性能研究[J].中华放射学杂志,2003,37(11):1036-1042. 被引量:27
  • 2刘灵芝,侯翠红,刘恒亮.冠脉内支架植入术后再狭窄的影响因素分析[J].郑州大学学报(医学版),2005,40(3):533-535. 被引量:8
  • 3陈竹君,赵洪磊,周颖玲,陈纪言,罗建方,李喻辉,李光,黄文晖,谭宁.雷帕霉素洗脱支架与紫杉醇涂层支架治疗冠状动脉复杂病变[J].岭南心血管病杂志,2006,12(3):175-177. 被引量:2
  • 4易玉海.血管支架在布-加综合征治疗中的应用[J].临床外科杂志,2007,15(3):159-160. 被引量:2
  • 5Zhang J. Stent thrombosis in patients with coronary artery disease treated with biodegradable polymer drug-eluting stents: an update meta-analysis [ J ]. Int Heart J ,2014,55 (3) :213 -218.
  • 6泽雯.国产完全可降解支架与国际同步[N/OL].中国医药报,2013-09-26.(2013-09-26)[2014-08-10].http://www.yybnet.com/sitel/zgyyb/html/2013-09/26/content_116257.htm.
  • 7Alfonso F. New Drug-eluting stents: polymer-free, biode- gradable polymers or bioabsorbable scaffolds? [ J ]. Rev Esp Cardiol(Engl Ed) ,2013,66(6) :423 -426.
  • 8Takimura CK, Campos CA, Melo PH, et al. Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release [ J ]. Arq Sras Cardiol, 2014, 102 ( 5 ) : 432 - 440.
  • 9Ribeiro EE, Campos CM, Ribeiro HB, et al. First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt- chromium alloy: INSPIRON-I trim [ J ]. EuroIntervention, 2014,9(12) :1 380 -1 384.
  • 10Sun LX,Zhang J. Biodegradable polymer DES versus dura- ble polymer everolimus-eluting stents for patients undergo- ing PCI: a meta-analysis [ J]. Heart Lung Circ, 2014,23 (6) :496 -502.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部